20-AUG-2024- Inter alia, approved:- 1. Recommended payment of final dividend of Rs. 13 per equity share (face value of Rs. 2 per equity share) for the financial year ended 31st March 2024. The dividend, upon approval by the shareholders, will be paid within 30 days from the date of the Annual General Meeting. The record date for the purpose of payment of final dividend, if declared, shall be 2nd August 2024. 2. Decided to hold the 88th Annual General Meeting (?AGM?) of the Company on Tuesday, 20th August 2024. 3. Noted that Mr. S. Radhakrishnan (DIN: 02313000), Non-Executive Director is not seeking reappointment and will retire upon conclusion of the 88th AGM of the Company. 4. Approved the appointment of Mr. Sanjay Varughese Joseph, Vice President and Head ? API Business as Senior Management Personnel with effect from 1 st June 2024. 5. Approved the appointment of M/s Joshi Apte & Associates, Cost Accountants (Firm Registration no. 000240) as Cost Auditors of the Company for FY 2024-25. 6. Approved the grant of stock options and employee stock appreciation rights (ESARs) in terms of the Cipla Employee Stock Option Scheme 2013-A and the Cipla Employee Stock Appreciation Rights Scheme 2021
STOCK | IND.AVG. | RELATIVE TO IND. | |
---|---|---|---|
Price/Earning TTM | 28.2735 | 29.7000 | |
Price/Book | 3.1100 | 1.5600 | |
Price/Sales TTM | 3.7200 | 9.1000 | |
Rev Growth (3 yrs Avg.) | 4.5500 | 23.8900 | |
EPS Growth (3 yrs Avg.) | 10.7400 | -35.4100 | |
ROE TTM | 12.8500 | 0.5300 | |
Debt/Equity | 0.0200 | -0.2800 | |
ROC TTM | 18.1900 | 6.5900 | |
Dividend Yield | 0.9400 | 0.3800 | |
PBIDTM % | 27.31 | -74.07 | |
PBTM % | 22.12 | -111.01 | |
PATM % | 16.12 | -95.47 |
Stock | LTP(CHG%) | Intraday |
---|---|---|
Ranbaxy .. | 859.80 (5.63) | |
Zydus L .. | 1121.10 (1.55) | |
JB Chem .. | 1865.00 (1.19) | |
Biocon | 308.00 (1.13) | |
Pfizer | 4500.00 (0.60) |